Reverin 135

For the treatment of heartwater, tick-borne gall sickness (anaplasmosis), pneumonia, navel ill, joint ill and footrot in stock and strangles in horses.

FOR ANIMAL USE ONLY

Reg. No. G3432 (Act 36/1947)

Namibia Reg. No. V04/17.1.2/552 [NS0]

Long- and short acting oxytetracycline injection.

INDICATIONS

For the treatment of heartwater, tick-borne gallsickness (anaplasmosis), pneumonia, navel ill, joint ill and foot rot in stock and strangles in horses.

COMPOSITION

A sterile, stable solution of oxytetracycline. It contains the equivalent of oxytetracycline hydrochloride 135 mg/mℓ (as the magnesium complex).

STORAGE

  • Store at or below 25 °C in a cool dry place.
  • Do not freeze.
  • Store in the original package in order to protect from light.
  • Do not use Reverin 135 after the expiry date which is stated on the container label.

WARNINGS

Long- and short acting dose

  • Withdrawal period:

      Do not slaughter animals for human consumption within 28 days of last treatment. Milk from treated cows must not be used for human consumption within 7 days of treatment.

  • Dispose of any containers, disposable equipment and any other waste after use, in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008) and do not reuse for any other purpose.
  • Do not contaminate rivers, dams or any water sources with containers or waste.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

Administration

  • Intramuscular, subcutaneous or intravenous injection.
  • When injecting intramuscularly, inject into the muscle of the mid-neck area using a needle of not more than 30 mm in length.
  • Do not inject more than 20 mℓ at one site.
  • Massage the area after injection to enhance absorption and minimise swelling.
  • When using the intravenous route, inject slowly and pause if any discomfort is shown.
  • THE LONG-ACTING DOSE MUST BE ADMINISTERED BY THE INTRAMUSCULAR ROUTE ONLY.

Dosage: Normal Use

AnimalDiseaseDose
CattleHeartwater and tick-borne gallsickness (anaplasmosis)8 mℓ/100 kg body mass daily for 3 days.
Pneumonia, navel ill, foot rot and joint ill8 mℓ/100 kg body mass daily for 3 days.
HorsesFoot rot, navel ill, joint ill, pneumonia and strangles8 mℓ/100 kg body mass daily for 3 days.
Sheep and GoatsHeartwater4 mℓ/50 kg body mass daily for 3 days.
Foot rot, pneumonia, navel ill and joint ill4 mℓ/50 kg body mass daily for 3 days.
PigsFoot rot and pneumonia2 mℓ/30 kg body mass daily for 3 days.

Dosage: Long-acting use (When a higher efficacy and longer action is required)

AnimalDiseaseDose
CattleHeartwater and tick-borne gallsickness (anaplasmosis)16 mℓ/100 kg body mass. Repeat after 3 days if necessary.
Pneumonia, navel ill, foot rot and joint ill16 mℓ/100 kg body mass. Repeat after 3 days if necessary.
Sheep and goatsHeartwater8 mℓ/50 kg body mass. Repeat after 3 days if necessary.
Foot rot, pneumonia, navel ill and joint ill8 mℓ/50 kg body mass. Repeat after 3 days if necessary.

N.B. For rapid recovery, a prompt and accurate diagnosis is essential. It is, therefore, always advisable to consult your veterinarian for a correct diagnosis.

SIDE EFFECTS AND SPECIAL PRECAUTIONS

  • Hypersensitivity reactions are known to occur with the use of certain classes of antibiotics. These reactions can range from mild, transient skin reactions to fatal anaphylactoid shock. If administered to an animal that is hypersensitive, anaphylactic shock may occur.
  • Adrenaline, corticosteroids and antihistamines should be administered to treat anaphylaxis.
  • If known hypersensitivity exist in an individual or group of animals, this product should be used with caution and only after consulting with a veterinarian.
  • Use of injectable medicinal preparations may result in localised tissue reactions and temporary swelling at the injection site. Treatment is symptomatic and supportive.
  • Natural bacterial resistance may develop to antibiotic preparations. If this is suspected please consult with your veterinarian.

PRESENTATION

100 mℓ and 500 mℓ multi-dose glass vials.

REGISTRATION HOLDER                                            

Intervet South Africa (Pty) Ltd.                                 

20 Spartan Road, Spartan                                            

1619, RSA                                                                            

Tel: +27 (0) 11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT

11 December 2014